These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1775 related articles for article (PubMed ID: 16518375)

  • 21. Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.
    Fruci D; Cho WC; Nobili V; Locatelli F; Alisi A
    Curr Drug Metab; 2016; 17(4):308-16. PubMed ID: 26694726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance revisited: looking back at 10 years of multidrug resistance research.
    Schmidt C
    J Natl Cancer Inst; 2008 Oct; 100(20):1428-9. PubMed ID: 18840811
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
    Joyce H; McCann A; Clynes M; Larkin A
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.
    Li Y; Revalde JL; Reid G; Paxton JW
    Drug Metab Rev; 2010 Nov; 42(4):590-611. PubMed ID: 20433315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs.
    Lim MMK; Wee JWK; Soong JC; Chua D; Tan WR; Lizwan M; Li Y; Teo Z; Goh WWB; Zhu P; Tan NS
    Mol Cancer; 2018 Oct; 17(1):152. PubMed ID: 30342537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
    Deng J; Shao J; Markowitz JS; An G
    Pharm Res; 2014 Sep; 31(9):2237-55. PubMed ID: 24842659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
    Yu M; Ocana A; Tannock IF
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABC-transporters: implications on drug resistance from microorganisms to human cancers.
    Lage H
    Int J Antimicrob Agents; 2003 Sep; 22(3):188-99. PubMed ID: 13678820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and strategies to overcome multiple drug resistance in cancer.
    Ozben T
    FEBS Lett; 2006 May; 580(12):2903-9. PubMed ID: 16497299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans.
    Chambers CS; Viktorová J; Řehořová K; Biedermann D; Turková L; Macek T; Křen V; Valentová K
    J Agric Food Chem; 2020 Feb; 68(7):1763-1779. PubMed ID: 30907588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multidrug resistance-associated proteins and their roles in multidrug resistance].
    Zhang H; Fu LW
    Yao Xue Xue Bao; 2011 May; 46(5):479-86. PubMed ID: 21800532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigational ABC transporter inhibitors.
    Falasca M; Linton KJ
    Expert Opin Investig Drugs; 2012 May; 21(5):657-66. PubMed ID: 22493979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressors as multidrug resistance reversal agents.
    Morjani H; Madoulet C
    Methods Mol Biol; 2010; 596():433-46. PubMed ID: 19949935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
    Cascorbi I; Haenisch S
    Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.